F S&P 500
5,203.75 -9.00 (-0.17%) F Dow Jones
39,150.00 -45.00 (-0.11%) F Nasdaq
18,140.00 -46.50 (-0.26%) E-mini Russell 2000 Index Futur
2,057.40 -7.40 (-0.36%) Petróleo
79.68 +0.69 (+0.87%) Oro
2,319.80 -2.50 (-0.11%)
Minerva Surgical, Inc. (UTRS)
Minerva Surgical, Inc.
4255 Burton Drive
Santa Clara, CA 95054
United States
855 646 7874
https://minervasurgical.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 174
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Todd Usen | President, CEO & Director | N/D | N/D | 1967 |
| Mr. Greg Simbro | Vice President of Finance | N/D | N/D | N/D |
| Mr. Erik Reese | Vice President of Sales | N/D | N/D | N/D |
| Ms. Wendy Bowman | Vice President of Human Resources | N/D | N/D | N/D |
| Dr. Evgueni V. Skalnyi M.D. | Chief Medical Officer | 365.25k | N/D | 1966 |
| Ms. Joanne Long | Vice President of Corporate Controller | N/D | N/D | N/D |
Descripción
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Gestión corporativa
La calificación ISS Governance QuickScore de Minerva Surgical, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
